search
Back to results

Dietary Lipids, Energy Expenditure and Obesity Biomarkers

Primary Purpose

Obesity

Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Group 1 - diet rich in n-3 and n-6 PUFA
Group 2 - diet rich in MUFA
Group 3 - Placebo group
Sponsored by
Universidade Federal do Rio de Janeiro
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Obesity focused on measuring obesity, lipids, energy expenditure, gene expression

Eligibility Criteria

20 Years - 39 Years (Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • obesity grades I and II (body mass index between 30 and 39,99 kg/m2);
  • completion of basic education (former 4th primary series).

Exclusion Criteria:

  • menopausal;
  • weight loss more than three kilograms (3 kg) in the last three months;
  • diagnosis of diabetes mellitus, heart disease, hypertension, nephropathy, liver diseases , thyroid dysfunction; gastrointestinal disorders , acquired immunodeficiency syndrome or cancer;
  • cholecystectomy in the past 12 months and other recent surgeries;
  • pregnancy or lactation;
  • smokers;
  • drugs to lipid-lowering, diabetes, hypertension, depression, or obesity;
  • food history of allergy or intolerance to vegetable oils (olive oil, soy or canola), fish oil, fish and / or seafood.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm 3

    Arm Type

    Experimental

    Experimental

    Experimental

    Arm Label

    Group 1 - diet rich in n-3 and n-6 PUFA

    Group 2 - diet rich in MUFA

    Group 3 - Placebo group

    Arm Description

    Assigned intervention: The dietary intervention was conducted by 60 days. Were prescribed normocaloric diets with similar macronutrient composition, varying only the type of lipids offered. Group 1 received diet rich in n-3 and n-6 polyunsaturated fatty acids (PUFA). The volunteers were asked to consume daily a mixture of virgin olive oil and soybean oil, totaling 35.2g to 52.8g, and 2 g of fish oil.

    Assigned intervention: The dietary intervention was conducted by 60 days. Were prescribed normocaloric diets with similar macronutrient composition, varying only the type of lipids offered. Group 2 received diet rich in monounsaturated fatty acids (MUFA). The volunteers were asked to consume daily virgin olive oil, totaling 35.2g to 50.6g, and 1 capsule of 1g of soybean oil.

    Placebo group was instructed to keep their eating habits and consuming 1 sachet of 2g of soybean oil and 1 capsule of 1g of soybean oil by day.

    Outcomes

    Primary Outcome Measures

    Compare the effects of modulation of PUFA and MUFA in energy expenditure of obese women
    The energy expenditure was evaluated by indirect calorimetry (Vmax Encore 29 Systems®)

    Secondary Outcome Measures

    Effects of modulation of PUFA and MUFA in body weight of obese women
    Effects of modulation of PUFA and MUFA in body composition of obese women
    The body composition was evaluated by electrical bioimpedance
    Effects of modulation of PUFA and MUFA in feeding behavior of obese women
    Feeding behavior was evaluated by Three Factor Eating Questionnaire
    Effects of modulation of PUFA and MUFA in gene expression of obese women
    Gene expression of PPARα and PPARγ2 in adipose tissue
    Effects of modulation of PUFA and MUFA in blood glucose of obese women
    Effects of modulation of PUFA and MUFA in blood insulin of obese women
    Effects of modulation of PUFA and MUFA in insulin resistance of obese women
    Insulin resistance was evaluated by Homeostasis Model Assessment
    Effects of modulation of PUFA and MUFA in insulin sensitivity of obese women
    Insulin resistance was evaluated by Quantitative Insulin Sensitivity Check Index
    Effects of modulation of PUFA and MUFA in total cholesterol and fractions of obese women
    total cholesterol and fractions and triglycerides
    Effects of modulation of PUFA and MUFA in adiponectin of obese women
    serum adiponectin
    Effects of modulation of PUFA and MUFA in leptin of obese women
    serum leptin
    Effects of modulation of PUFA and MUFA in TNF alpha of obese women
    serum TNF alpha
    Effects of modulation of PUFA and MUFA in interleukin 6 of obese women
    serum interleukin 6

    Full Information

    First Posted
    January 7, 2016
    Last Updated
    January 12, 2016
    Sponsor
    Universidade Federal do Rio de Janeiro
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT02656940
    Brief Title
    Dietary Lipids, Energy Expenditure and Obesity Biomarkers
    Official Title
    Effects of Dietary Lipid Modulation in Energy Expenditure, Body Composition, Obesity-related Biomarkers and Gene Expression of Peroxisome Proliferator-Activated Receptors Alpha and Gamma 2 in Adipose Tissue of Obese Women
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    January 2016
    Overall Recruitment Status
    Completed
    Study Start Date
    February 2013 (undefined)
    Primary Completion Date
    May 2014 (Actual)
    Study Completion Date
    July 2014 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Universidade Federal do Rio de Janeiro

    4. Oversight

    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    The purpose of this study is to determine whether the modulation of dietary lipids are effective in the treatment of obesity and comorbidities.
    Detailed Description
    Obesity is a complex disease of multifactorial etiology and difficult to control. Among lifestyle changes proposed to the treatment of this disease and comorbidities, there is the modulation of dietary lipid composition. This study aimed to evaluate the effects of the modulation of fatty acid (FA) polyunsaturated (PUFA) and monounsaturated (MUFA) in energy expenditure (EE), weight loss, body composition, lipid and glycemic profile, free fatty acids (FFA), glycerol, adiponectin, leptin, blood pressure (BP), feeding behavior and expression of PPARα and PPARγ2 genes in adipose tissue (AT) of obese women. It was conducted a parallel, randomized, controlled, single-blind study with dietary intervention (DI) for 60 days, where 32 women with obesity classes I and II were distributed into three groups: G1 = diet rich in n-3 PUFA and n-6 (n = 10); G2 = MUFA-rich diet (n = 11); and G3 = control (n = 11). For G1 and G2 were prescribed normocaloric diets with similar macronutrient composition, varying only the type of lipids offered. In order to achieve the desired intake of unsaturated FA, both groups received individual portions of vegetable oils in the form of sachets, which were consumed for lunch and dinner (G1 = mix of virgin olive oil [VOO] and soybean oil [SO], overall of 35.2g to 52.8g / day; G2 = VOO, overall of 35.2g to 50.6 g / day), besides gelatin capsules (G1 = 2 g of fish oil / day; G2 = 1 capsule of 1g of SO / day). G3 was instructed to keep their eating habits and consuming placebos (1 sachet of 2g of SO and 1 capsule of 1g of SO / day).

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Obesity
    Keywords
    obesity, lipids, energy expenditure, gene expression

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    Participant
    Allocation
    Randomized
    Enrollment
    32 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    Group 1 - diet rich in n-3 and n-6 PUFA
    Arm Type
    Experimental
    Arm Description
    Assigned intervention: The dietary intervention was conducted by 60 days. Were prescribed normocaloric diets with similar macronutrient composition, varying only the type of lipids offered. Group 1 received diet rich in n-3 and n-6 polyunsaturated fatty acids (PUFA). The volunteers were asked to consume daily a mixture of virgin olive oil and soybean oil, totaling 35.2g to 52.8g, and 2 g of fish oil.
    Arm Title
    Group 2 - diet rich in MUFA
    Arm Type
    Experimental
    Arm Description
    Assigned intervention: The dietary intervention was conducted by 60 days. Were prescribed normocaloric diets with similar macronutrient composition, varying only the type of lipids offered. Group 2 received diet rich in monounsaturated fatty acids (MUFA). The volunteers were asked to consume daily virgin olive oil, totaling 35.2g to 50.6g, and 1 capsule of 1g of soybean oil.
    Arm Title
    Group 3 - Placebo group
    Arm Type
    Experimental
    Arm Description
    Placebo group was instructed to keep their eating habits and consuming 1 sachet of 2g of soybean oil and 1 capsule of 1g of soybean oil by day.
    Intervention Type
    Dietary Supplement
    Intervention Name(s)
    Group 1 - diet rich in n-3 and n-6 PUFA
    Intervention Description
    In order to achieve the desired intake of unsaturated FA, the group received individual portions of vegetable oils in the form of sachets, which were consumed for lunch and dinner, besides gelatin capsules, for 60 days.
    Intervention Type
    Dietary Supplement
    Intervention Name(s)
    Group 2 - diet rich in MUFA
    Intervention Description
    In order to achieve the desired intake of unsaturated FA, the group received individual portions of vegetable oils in the form of sachets, which were consumed for lunch and dinner, besides gelatin capsules, for 60 days.
    Intervention Type
    Dietary Supplement
    Intervention Name(s)
    Group 3 - Placebo group
    Intervention Description
    Placebo group was instructed to keep their eating habits and consuming placebo for 60 days.
    Primary Outcome Measure Information:
    Title
    Compare the effects of modulation of PUFA and MUFA in energy expenditure of obese women
    Description
    The energy expenditure was evaluated by indirect calorimetry (Vmax Encore 29 Systems®)
    Time Frame
    Change from baseline energy expenditure at 2 months
    Secondary Outcome Measure Information:
    Title
    Effects of modulation of PUFA and MUFA in body weight of obese women
    Time Frame
    Change from baseline loss of body weight at 2 months
    Title
    Effects of modulation of PUFA and MUFA in body composition of obese women
    Description
    The body composition was evaluated by electrical bioimpedance
    Time Frame
    Change from baseline body composition at 2 months
    Title
    Effects of modulation of PUFA and MUFA in feeding behavior of obese women
    Description
    Feeding behavior was evaluated by Three Factor Eating Questionnaire
    Time Frame
    Change from baseline feeding behavior at 2 months
    Title
    Effects of modulation of PUFA and MUFA in gene expression of obese women
    Description
    Gene expression of PPARα and PPARγ2 in adipose tissue
    Time Frame
    Change from baseline gene expression at 2 months
    Title
    Effects of modulation of PUFA and MUFA in blood glucose of obese women
    Time Frame
    Change from baseline blood glucose at 2 months
    Title
    Effects of modulation of PUFA and MUFA in blood insulin of obese women
    Time Frame
    Change from baseline blood insulin at 2 months
    Title
    Effects of modulation of PUFA and MUFA in insulin resistance of obese women
    Description
    Insulin resistance was evaluated by Homeostasis Model Assessment
    Time Frame
    Change from baseline insulin resistance at 2 months
    Title
    Effects of modulation of PUFA and MUFA in insulin sensitivity of obese women
    Description
    Insulin resistance was evaluated by Quantitative Insulin Sensitivity Check Index
    Time Frame
    Change from baseline insulin sensitivity at 2 months
    Title
    Effects of modulation of PUFA and MUFA in total cholesterol and fractions of obese women
    Description
    total cholesterol and fractions and triglycerides
    Time Frame
    Change from baseline total cholesterol and fractions at 2 months
    Title
    Effects of modulation of PUFA and MUFA in adiponectin of obese women
    Description
    serum adiponectin
    Time Frame
    Change from baseline adiponectin at 2 months
    Title
    Effects of modulation of PUFA and MUFA in leptin of obese women
    Description
    serum leptin
    Time Frame
    Change from baseline leptin at 2 months
    Title
    Effects of modulation of PUFA and MUFA in TNF alpha of obese women
    Description
    serum TNF alpha
    Time Frame
    Change from baseline TNF alpha at 2 months
    Title
    Effects of modulation of PUFA and MUFA in interleukin 6 of obese women
    Description
    serum interleukin 6
    Time Frame
    Change from baseline interleukin 6 at 2 months

    10. Eligibility

    Sex
    Female
    Minimum Age & Unit of Time
    20 Years
    Maximum Age & Unit of Time
    39 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: obesity grades I and II (body mass index between 30 and 39,99 kg/m2); completion of basic education (former 4th primary series). Exclusion Criteria: menopausal; weight loss more than three kilograms (3 kg) in the last three months; diagnosis of diabetes mellitus, heart disease, hypertension, nephropathy, liver diseases , thyroid dysfunction; gastrointestinal disorders , acquired immunodeficiency syndrome or cancer; cholecystectomy in the past 12 months and other recent surgeries; pregnancy or lactation; smokers; drugs to lipid-lowering, diabetes, hypertension, depression, or obesity; food history of allergy or intolerance to vegetable oils (olive oil, soy or canola), fish oil, fish and / or seafood.
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Eliane L Rosado, Doctor
    Organizational Affiliation
    UFRJ
    Official's Role
    Study Director

    12. IPD Sharing Statement

    Citations:
    PubMed Identifier
    16516300
    Citation
    Ailhaud G, Massiera F, Weill P, Legrand P, Alessandri JM, Guesnet P. Temporal changes in dietary fats: role of n-6 polyunsaturated fatty acids in excessive adipose tissue development and relationship to obesity. Prog Lipid Res. 2006 May;45(3):203-36. doi: 10.1016/j.plipres.2006.01.003. Epub 2006 Feb 10.
    Results Reference
    background
    PubMed Identifier
    21903140
    Citation
    Barson JR, Karatayev O, Gaysinskaya V, Chang GQ, Leibowitz SF. Effect of dietary fatty acid composition on food intake, triglycerides, and hypothalamic peptides. Regul Pept. 2012 Jan 10;173(1-3):13-20. doi: 10.1016/j.regpep.2011.08.012. Epub 2011 Sep 6.
    Results Reference
    background
    PubMed Identifier
    22492369
    Citation
    Bjermo H, Iggman D, Kullberg J, Dahlman I, Johansson L, Persson L, Berglund J, Pulkki K, Basu S, Uusitupa M, Rudling M, Arner P, Cederholm T, Ahlstrom H, Riserus U. Effects of n-6 PUFAs compared with SFAs on liver fat, lipoproteins, and inflammation in abdominal obesity: a randomized controlled trial. Am J Clin Nutr. 2012 May;95(5):1003-12. doi: 10.3945/ajcn.111.030114. Epub 2012 Apr 4.
    Results Reference
    background
    PubMed Identifier
    19460115
    Citation
    Buckley JD, Howe PR. Anti-obesity effects of long-chain omega-3 polyunsaturated fatty acids. Obes Rev. 2009 Nov;10(6):648-59. doi: 10.1111/j.1467-789X.2009.00584.x. Epub 2009 May 12.
    Results Reference
    background
    PubMed Identifier
    19010571
    Citation
    Casas-Agustench P, Lopez-Uriarte P, Bullo M, Ros E, Gomez-Flores A, Salas-Salvado J. Acute effects of three high-fat meals with different fat saturations on energy expenditure, substrate oxidation and satiety. Clin Nutr. 2009 Feb;28(1):39-45. doi: 10.1016/j.clnu.2008.10.008. Epub 2008 Nov 17.
    Results Reference
    background
    PubMed Identifier
    12079856
    Citation
    Clarke SD, Gasperikova D, Nelson C, Lapillonne A, Heird WC. Fatty acid regulation of gene expression: a genomic explanation for the benefits of the mediterranean diet. Ann N Y Acad Sci. 2002 Jun;967:283-98.
    Results Reference
    background
    PubMed Identifier
    25446217
    Citation
    Clevenger HC, Stevenson JL, Cooper JA. Metabolic responses to dietary fatty acids in obese women. Physiol Behav. 2015 Feb;139:73-9. doi: 10.1016/j.physbeh.2014.11.022. Epub 2014 Nov 13.
    Results Reference
    background
    PubMed Identifier
    21159785
    Citation
    DeFina LF, Marcoux LG, Devers SM, Cleaver JP, Willis BL. Effects of omega-3 supplementation in combination with diet and exercise on weight loss and body composition. Am J Clin Nutr. 2011 Feb;93(2):455-62. doi: 10.3945/ajcn.110.002741. Epub 2010 Dec 15.
    Results Reference
    background
    PubMed Identifier
    14694208
    Citation
    Flint A, Helt B, Raben A, Toubro S, Astrup A. Effects of different dietary fat types on postprandial appetite and energy expenditure. Obes Res. 2003 Dec;11(12):1449-55. doi: 10.1038/oby.2003.194.
    Results Reference
    background
    PubMed Identifier
    19776622
    Citation
    Guri AJ, Hontecillas R, Bassaganya-Riera J. Dietary modulators of peroxisome proliferator-activated receptors: implications for the prevention and treatment of metabolic syndrome. J Nutrigenet Nutrigenomics. 2008;1(3):126-35. doi: 10.1159/000112460. Epub 2008 Feb 20.
    Results Reference
    background
    PubMed Identifier
    16552404
    Citation
    Krebs JD, Browning LM, McLean NK, Rothwell JL, Mishra GD, Moore CS, Jebb SA. Additive benefits of long-chain n-3 polyunsaturated fatty acids and weight-loss in the management of cardiovascular disease risk in overweight hyperinsulinaemic women. Int J Obes (Lond). 2006 Oct;30(10):1535-44. doi: 10.1038/sj.ijo.0803309. Epub 2006 Mar 21.
    Results Reference
    background
    PubMed Identifier
    24363161
    Citation
    Krishnan S, Cooper JA. Effect of dietary fatty acid composition on substrate utilization and body weight maintenance in humans. Eur J Nutr. 2014 Apr;53(3):691-710. doi: 10.1007/s00394-013-0638-z. Epub 2013 Dec 22.
    Results Reference
    background
    PubMed Identifier
    20022469
    Citation
    Liao FH, Liou TH, Shieh MJ, Chien YW. Effects of different ratios of monounsaturated and polyunsaturated fatty acids to saturated fatty acids on regulating body fat deposition in hamsters. Nutrition. 2010 Jul-Aug;26(7-8):811-7. doi: 10.1016/j.nut.2009.09.009. Epub 2009 Dec 22.
    Results Reference
    background
    PubMed Identifier
    24362249
    Citation
    Nakamura MT, Yudell BE, Loor JJ. Regulation of energy metabolism by long-chain fatty acids. Prog Lipid Res. 2014 Jan;53:124-44. doi: 10.1016/j.plipres.2013.12.001. Epub 2013 Dec 18.
    Results Reference
    background
    PubMed Identifier
    23546614
    Citation
    Mejia-Barradas CM, Del-Rio-Navarro BE, Dominguez-Lopez A, Campos-Rodriguez R, Martinez-Godinez Md, Rojas-Hernandez S, Lara-Padilla E, Abarca-Rojano E, Miliar-Garcia A. The consumption of n-3 polyunsaturated fatty acids differentially modulates gene expression of peroxisome proliferator-activated receptor alpha and gamma and hypoxia-inducible factor 1 alpha in subcutaneous adipose tissue of obese adolescents. Endocrine. 2014 Feb;45(1):98-105. doi: 10.1007/s12020-013-9941-y. Epub 2013 Apr 2.
    Results Reference
    background
    PubMed Identifier
    19828712
    Citation
    van Dijk SJ, Feskens EJ, Bos MB, Hoelen DW, Heijligenberg R, Bromhaar MG, de Groot LC, de Vries JH, Muller M, Afman LA. A saturated fatty acid-rich diet induces an obesity-linked proinflammatory gene expression profile in adipose tissue of subjects at risk of metabolic syndrome. Am J Clin Nutr. 2009 Dec;90(6):1656-64. doi: 10.3945/ajcn.2009.27792. Epub 2009 Oct 14.
    Results Reference
    background

    Learn more about this trial

    Dietary Lipids, Energy Expenditure and Obesity Biomarkers

    We'll reach out to this number within 24 hrs